These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 15533890)

  • 1. GW9662, a potent antagonist of PPARgamma, inhibits growth of breast tumour cells and promotes the anticancer effects of the PPARgamma agonist rosiglitazone, independently of PPARgamma activation.
    Seargent JM; Yates EA; Gill JH
    Br J Pharmacol; 2004 Dec; 143(8):933-7. PubMed ID: 15533890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological manipulation of peroxisome proliferator-activated receptor γ (PPARγ) reveals a role for anti-oxidant protection in a model of Parkinson's disease.
    Martin HL; Mounsey RB; Mustafa S; Sathe K; Teismann P
    Exp Neurol; 2012 Jun; 235(2):528-38. PubMed ID: 22417924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3.
    Magenta G; Borenstein X; Rolando R; Jasnis MA
    BMC Cancer; 2008 Feb; 8():47. PubMed ID: 18261208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of lymphoma cell proliferation by peroxisomal proliferator-activated receptor-γ ligands via Wnt signaling pathway.
    Liu JJ; Dai XJ; Xu Y; Liu PQ; Zhang Y; Liu XD; Fang ZG; Lin DJ; Xiao RZ; Huang RW; Huang HQ
    Cell Biochem Biophys; 2012 Jan; 62(1):19-27. PubMed ID: 21837368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPARgamma agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms.
    Yi JH; Park SW; Brooks N; Lang BT; Vemuganti R
    Brain Res; 2008 Dec; 1244():164-72. PubMed ID: 18948087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma.
    Kim KR; Choi HN; Lee HJ; Baek HA; Park HS; Jang KY; Chung MJ; Moon WS
    Oncol Rep; 2007 Oct; 18(4):825-32. PubMed ID: 17786342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of peroxisome proliferator-activated receptor gamma prevents high-fat diet-induced obesity in vivo.
    Nakano R; Kurosaki E; Yoshida S; Yokono M; Shimaya A; Maruyama T; Shibasaki M
    Biochem Pharmacol; 2006 Jun; 72(1):42-52. PubMed ID: 16696951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPARγ Modulation of Cytokine-Stimulated MUC16 (CA125) Expression in Breast and Ovarian Cancer-Derived Cells.
    Morgado M; Carson DD
    J Cell Biochem; 2017 Jan; 118(1):163-171. PubMed ID: 27292441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of peroxisome proliferator-activated receptor gamma in brain inhibits inflammatory pain, dorsal horn expression of Fos, and local edema.
    Morgenweck J; Abdel-Aleem OS; McNamara KC; Donahue RR; Badr MZ; Taylor BK
    Neuropharmacology; 2010 Feb; 58(2):337-45. PubMed ID: 19891980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines.
    Morosetti R; Servidei T; Mirabella M; Rutella S; Mangiola A; Maira G; Mastrangelo R; Koeffler HP
    Int J Oncol; 2004 Aug; 25(2):493-502. PubMed ID: 15254749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosiglitazone sensitizes MDA-MB-231 breast cancer cells to anti-tumour effects of tumour necrosis factor-alpha, CH11 and CYC202.
    Mody M; Dharker N; Bloomston M; Wang PS; Chou FS; Glickman TS; McCaffrey T; Yang Z; Pumfery A; Lee D; Ringel MD; Pinzone JJ
    Endocr Relat Cancer; 2007 Jun; 14(2):305-15. PubMed ID: 17639046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of rosiglitazone on the acid-induced intracellular generation of hydrogen peroxide in cultured feline esophageal epithelial cells.
    Park SY; Sohn UD
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Feb; 383(2):191-201. PubMed ID: 21212935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor gamma activation inhibits progesterone-stimulated human MUC1 expression.
    Wang P; Dharmaraj N; Brayman MJ; Carson DD
    Mol Endocrinol; 2010 Jul; 24(7):1368-79. PubMed ID: 20484415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of peroxisome proliferator-activated receptor gamma in human cervical carcinoma.
    Jung TI; Baek WK; Suh SI; Jang BC; Song DK; Bae JH; Kwon KY; Bae JH; Cha SD; Bae I; Cho CH
    Gynecol Oncol; 2005 May; 97(2):365-73. PubMed ID: 15863131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents.
    Tureyen K; Kapadia R; Bowen KK; Satriotomo I; Liang J; Feinstein DL; Vemuganti R
    J Neurochem; 2007 Apr; 101(1):41-56. PubMed ID: 17394460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor γ ligands retard cultured vascular smooth muscle cells calcification induced by high glucose.
    Zhou YB; Zhang J; Peng DQ; Chang JR; Cai Y; Yu YR; Jia MZ; Wu W; Guan YF; Tang CS; Qi YF
    Cell Biochem Biophys; 2013 Jul; 66(3):421-9. PubMed ID: 23274912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor gamma antagonists decrease Na+ transport via the epithelial Na+ channel.
    Pavlov TS; Levchenko V; Karpushev AV; Vandewalle A; Staruschenko A
    Mol Pharmacol; 2009 Dec; 76(6):1333-40. PubMed ID: 19752200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective effects of PPARgamma agonists and antagonists on human pre-adipocyte differentiation.
    Leyvraz C; Suter M; Verdumo C; Calmes JM; Paroz A; Darimont C; Gaillard RC; Pralong FP; Giusti V
    Diabetes Obes Metab; 2010 Mar; 12(3):195-203. PubMed ID: 19895635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
    Lin MS; Chen WC; Bai X; Wang YD
    J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor β/δ and γ agonists differentially affect prostaglandin E2 and cytokine synthesis and nutrient transporter expression in porcine trophoblast cells during implantation.
    Blitek A; Szymanska M
    Theriogenology; 2020 Aug; 152():36-46. PubMed ID: 32361305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.